EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Novel Aurone Derivative Ameliorates MASH Lipid Metabolism via the AMPK-ACC-PPARα Axis

Sule Bai, Yi Zou, Wenyi Zhang, Jiajia Yu, Zhenzhen Qie, Zhen Liu iD, Peng Yu, Cen Xiang, Yuou Teng iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms262211099 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Sule Bai und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Biological Engineering, Tianjin University of Science and Technology, Tianjin 300457, China. Hauptthemen laut MEDLINE: PPAR alpha, Lipid Metabolism, AMP-Activated Protein Kinases, Fatty Liver. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tianjin Science and Technology Program Project, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic dysfunction-associated steatohepatitis (MASH), a progressive form of metabolic dysfunction-associated fatty liver disease (MASLD), is characterized by disrupted lipid metabolism and persistent inflammation, which can lead to cirrhosis and hepatocellular carcinoma. The novel pan-peroxisome proliferator-activated receptor (PPAR) agonist 1d has been previously shown to alleviate insulin resistance and hepatic steatosis in type 2 diabetic (T2DM) mice; however, its mechanism of action remains unclear. Our integrated in vitro and in vivo findings demonstrate that compound 1d significantly improves disordered hepatic lipid metabolism by modulating the AMPK-ACC-PPARα axis—specifically, by upregulating AMPK expression and phosphorylation, inhibiting ACC activity, downregulating FASN, and upregulating PPARα. Concurrently, 1d exhibits potent anti-inflammatory effects in both settings, effectively mitigating hepatic inflammation in a MASH mouse model. Therefore, compound 1d improves lipid metabolism through the AMPK-ACC-PPARα axis and additionally provides an anti-inflammatory benefit, highlighting its potential as a novel therapeutic candidate for MASH.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PPAR alphaLipid MetabolismAMP-Activated Protein KinasesFatty LiverAcetyl-CoA CarboxylaseAnimalsMiceHumansMaleSignal TransductionLiverMice, Inbred C57BLDisease Models, Animal

Stichwörter der Autor:innen

AMPK-ACC-PPARα axisMASHinflammationlipid metabolism

Substanzen

PPAR alphaAMP-Activated Protein KinasesAcetyl-CoA Carboxylase

Autor:innen und Institutionen

  • School of Biological Engineering, Tianjin University of Science and Technology, Tianjin 300457, China.

ORCID-Profile: Zhen Liu, Yuou Teng

Förderung

  • Tianjin Science and Technology Program Project
  • National Natural Science Foundation of China

Zitieren

APA

Bai, S., Zou, Y., Zhang, W., Yu, J., Qie, Z., Liu, Z., Yu, P., Xiang, C., & Teng, Y. (2025). Novel Aurone Derivative Ameliorates MASH Lipid Metabolism via the AMPK-ACC-PPARα Axis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262211099

Vancouver

Bai S, Zou Y, Zhang W, Yu J, Qie Z, Liu Z, et al. Novel Aurone Derivative Ameliorates MASH Lipid Metabolism via the AMPK-ACC-PPARα Axis. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262211099

BibTeX
@article{Bai2025,
  author = {Bai, Sule and Zou, Yi and Zhang, Wenyi and Yu, Jiajia and Qie, Zhenzhen and Liu, Zhen and Yu, Peng and Xiang, Cen and Teng, Yuou},
  title = {Novel Aurone Derivative Ameliorates MASH Lipid Metabolism via the AMPK-ACC-PPARα Axis},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms262211099}
}
Kostenlos starten →